data_1j4l_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1j4l _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.48 -0.248 . . . . 4.7300000000000004 112.48 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -93.82 10.58 32.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.523 0.201 . . . . 4.1200000000000001 111.263 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.441 ' HA2' ' OE1' ' A' ' 596' ' ' GLN . . . 138.25 4.34 1.75 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.483 -0.865 . . . . 1.49 113.081 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -108.24 137.12 46.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.98 0.39 . . . . 2.2999999999999998 111.068 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 698' ' ' ASP . 2.4 t80 -122.56 -55.52 1.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.104 -0.498 . . . . 1.3400000000000001 111.254 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.482 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 11.6 tp -113.0 142.98 45.08 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.942 0.401 . . . . 1.74 111.169 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 10.3 m -120.11 114.8 22.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.982 -0.554 . . . . 1.0700000000000001 111.437 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 592' ' ' LEU . 1.4 mp -105.36 109.08 20.93 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 106.889 -1.523 . . . . 1.77 106.889 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 12.4 ptpt -112.18 99.75 47.26 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 114.698 1.37 . . . . 2.1200000000000001 114.698 -176.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 0.602 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.8 Cg_exo -47.24 99.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 121.826 1.684 . . . . 0.23000000000000001 109.513 176.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.65 157.26 86.19 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.701 1.0 . . . . 1.8400000000000001 113.701 -176.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.406 ' HA ' ' HG3' ' A' ' 589' ' ' GLN . 76.3 Cg_exo -49.88 -25.75 12.65 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.583 2.855 . . . . 0.93000000000000005 112.934 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -61.95 -26.76 68.39 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.088 -0.708 . . . . 2.0099999999999998 109.088 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.423 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 2.9 t -95.82 154.08 17.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.998 -1.001 . . . . 1.0 109.866 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.455 ' CD1' ' CZ ' ' A' ' 688' ' ' PHE . 20.2 pt -55.91 -12.81 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.719 0.295 . . . . 1.8100000000000001 111.082 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . . . . . . . . . 17.9 mt -108.48 124.42 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.398 -0.364 . . . . 1.3999999999999999 111.77 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.406 ' HG3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -110.38 56.41 0.63 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.151 0.501 . . . . 1.5600000000000001 110.075 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 0.602 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 13.8 mt-10 -124.81 171.6 10.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.677 -0.692 . . . . 2.0499999999999998 111.378 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.23 126.38 40.81 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.994 0.426 . . . . 0.90000000000000002 110.866 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 580' ' ' LEU . 0.1 OUTLIER -112.4 137.13 51.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.916 -0.584 . . . . 2.6499999999999999 109.982 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -124.02 114.72 20.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.084 -0.246 . . . . 1.75 111.611 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.596 HG12 ' CD2' ' A' ' 601' ' ' PHE . 30.2 mt -71.54 109.66 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 120.789 0.328 . . . . 1.1299999999999999 110.536 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 0.8 OUTLIER -65.92 107.9 2.0 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.873 -0.788 . . . . 1.96 108.873 178.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.441 ' OE1' ' HA2' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -42.5 -31.01 0.39 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.06 0.457 . . . . 1.46 110.996 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -66.47 -23.19 71.84 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.828 -0.701 . . . . 1.04 113.145 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . . . . . . . . . 76.1 t -101.32 119.41 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 117.594 0.697 . . . . 1.2 111.616 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -139.13 123.47 11.33 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.902 -0.59 . . . . 0.69999999999999996 109.685 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.51 ' HB3' ' HB2' ' A' ' 626' ' ' PHE . 51.8 Cg_endo -90.04 160.51 34.24 Favored 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 124.555 -1.019 . . . . 0.42999999999999999 112.13 0.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.596 ' CD2' HG12 ' A' ' 594' ' ' ILE . 2.6 t80 -91.84 114.27 26.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.038 0.447 . . . . 0.27000000000000002 109.96 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.495 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 19.6 m-85 -92.14 137.91 31.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.742 -0.663 . . . . 0.56000000000000005 111.562 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.461 ' HA ' ' HB3' ' A' ' 611' ' ' CYS . 3.6 mp -125.79 146.09 32.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.652 -0.703 . . . . 1.0600000000000001 110.743 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 161.05 -172.51 37.33 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.202 -0.999 . . . . 0.19 113.511 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.47 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -67.26 -53.84 26.33 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.816 0.341 . . . . 1.3100000000000001 111.798 -179.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.45 127.89 33.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 1.1399999999999999 111.221 -179.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -54.49 -19.35 5.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.882 -0.599 . . . . 2.5299999999999998 111.08 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -53.76 -29.68 41.01 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.051 0.453 . . . . 1.4399999999999999 110.397 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . . . . . . . . . 61.5 m -73.85 133.6 43.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.708 -0.678 . . . . 0.56000000000000005 110.567 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -47.77 -28.0 2.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.986 0.422 . . . . 1.54 110.461 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 603' ' ' ILE . 43.3 t -111.94 142.3 44.51 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.278 -0.638 . . . . 0.63 109.278 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.33 105.25 14.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.045 0.757 . . . . 2.2799999999999998 113.045 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.419 HG13 ' CE2' ' A' ' 692' ' ' PHE . 37.5 mm -138.88 109.39 4.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.108 -0.951 . . . . 1.0800000000000001 109.027 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.67 106.39 16.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.489 0.662 . . . . 2.2400000000000002 112.395 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.465 ' HB3' ' CG ' ' A' ' 618' ' ' LEU . 1.3 t0 -130.27 108.06 9.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.795 -1.093 . . . . 1.47 108.64 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -40.18 -28.09 0.05 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.758 0.651 . . . . 1.46 112.758 -178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.16 -40.32 71.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.066 0.395 . . . . 2.4399999999999999 112.066 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.541 ' HB2' ' CG ' ' A' ' 622' ' ' HIS . 0.9 OUTLIER -89.4 159.25 17.4 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.971 0.415 . . . . 1.8300000000000001 111.726 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 9.5 m -79.12 168.46 19.59 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.926 -0.579 . . . . 1.6599999999999999 111.435 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' A' ' 606' ' ' SER . 2.3 mpt_? -50.07 -35.94 27.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.232 0.539 . . . . 2.3599999999999999 110.449 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . . . . . . . . . 22.6 t -124.83 64.55 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.337 -0.847 . . . . 1.73 109.461 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.541 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 10.3 t60 -49.66 -44.37 47.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.476 -0.783 . . . . 0.62 111.956 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.1 p -165.67 159.74 16.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.039 0.447 . . . . 1.28 111.784 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.495 ' CB ' ' HA ' ' A' ' 602' ' ' PHE . 52.2 p90 -143.65 147.35 34.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.736 -0.665 . . . . 1.45 110.827 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.437 ' CD1' ' CD1' ' A' ' 594' ' ' ILE . 65.6 mt -102.27 140.05 21.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.273 -0.422 . . . . 1.47 109.871 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.51 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.6 t80 -132.7 134.42 44.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.214 -0.448 . . . . 0.46999999999999997 110.856 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.421 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 22.6 ttmt -97.72 134.98 40.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.127 -0.488 . . . . 1.5800000000000001 110.207 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.437 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.23 158.15 45.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 2.52 112.081 -178.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.94 112.42 14.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.726 -0.67 . . . . 2.6499999999999999 110.307 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 644' ' ' LEU . 7.1 t60 -72.66 130.77 41.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.701 -0.682 . . . . 1.1799999999999999 111.119 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -153.25 131.43 11.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 1.78 111.133 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 31.3 m -92.86 -179.12 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 2.6400000000000001 111.094 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -70.03 -72.31 0.89 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.759 . . . . 2.7799999999999998 112.585 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -128.42 178.46 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 5.7000000000000002 110.87 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.43 44.08 2.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 2.9700000000000002 110.878 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 87.5 mtp -59.95 119.87 8.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 5.8099999999999996 110.941 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 68.42 -69.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 7.4500000000000002 110.958 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -79.67 142.93 35.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 5.04 110.846 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.8 m -112.3 96.33 34.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 3.6299999999999999 110.909 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.93 -154.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.544 2.163 . . . . 2.7200000000000002 112.088 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -62.92 -16.61 59.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 2.3100000000000001 111.603 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 78.75 -61.34 0.36 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.549 -0.296 . . . . 3.1800000000000002 110.972 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 178.18 74.24 0.06 OUTLIER Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.354 -0.926 . . . . 1.1499999999999999 113.142 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 630' ' ' HIS . 1.6 mp -108.26 -162.12 0.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.321 -0.252 . . . . 1.97 110.321 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.57 147.94 41.36 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.113 0.482 . . . . 1.5800000000000001 112.243 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.42 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -135.03 139.1 44.54 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.527 -0.761 . . . . 1.3 110.124 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.459 ' CG2' ' CE1' ' A' ' 577' ' ' PHE . 3.6 pt -88.95 130.38 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.36 0.6 . . . . 1.1200000000000001 111.589 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.542 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 96.3 m95 -111.31 143.66 41.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.192 -0.913 . . . . 0.34000000000000002 111.075 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.403 ' CB ' HD23 ' A' ' 672' ' ' LEU . 4.4 t80 -107.98 117.15 33.38 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.579 -0.526 . . . . 0.88 109.579 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.448 ' N ' ' O ' ' A' ' 624' ' ' PHE . 14.3 m -105.32 138.35 41.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.247 -0.433 . . . . 1.3799999999999999 111.566 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.446 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 57.6 t60 -119.59 133.29 55.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.102 -0.499 . . . . 0.32000000000000001 111.097 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 7.2 p -129.6 6.46 5.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.863 -0.608 . . . . 1.0800000000000001 111.374 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.41 150.07 36.26 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.835 -0.698 . . . . 0.34000000000000002 112.669 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 6.4 t -71.59 -38.13 70.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.144 0.497 . . . . 1.5800000000000001 111.419 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 656' ' ' VAL . 2.6 m-80 -68.52 -3.88 13.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.619 -0.719 . . . . 1.8999999999999999 112.267 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' A' ' 655' ' ' ASN . 0.3 OUTLIER 54.79 124.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.207 0.527 . . . . 1.6499999999999999 111.575 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.446 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 75.4 p -87.7 166.47 14.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.794 -0.639 . . . . 1.6000000000000001 110.301 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -129.75 119.57 23.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.808 0.337 . . . . 1.02 110.692 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.5 ' HB3' ' CD2' ' A' ' 670' ' ' PHE . 0.7 OUTLIER -101.25 111.14 23.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 1.46 111.514 -179.514 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 55.72 -82.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 1.9399999999999999 111.163 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 659' ' ' LEU . 5.3 m-20 -136.5 7.57 3.06 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.826 0.306 . . . . 2.52 111.826 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.38 141.14 43.83 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.878 0.371 . . . . 2.0 110.995 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -79.79 141.42 36.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 3.2599999999999998 111.153 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.438 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 44.1 mmm -116.24 100.78 8.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 1.29 110.921 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 33.0 pt -87.88 140.97 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 1.24 110.762 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -39.4 101.85 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.269 -0.423 . . . . 0.95999999999999996 111.68 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 109.64 37.22 1.93 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.909 -0.663 . . . . 0.32000000000000001 112.456 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 668' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.97 160.31 27.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.961 0.41 . . . . 1.23 111.344 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.3 ttpm? -128.05 149.08 50.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.848 -0.615 . . . . 1.27 110.141 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.5 ' CD2' ' HB3' ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.87 143.63 27.55 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.398 0.518 . . . . 1.5900000000000001 112.398 -178.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.542 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.41 138.63 53.74 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.191 -0.459 . . . . 1.9399999999999999 109.778 178.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.403 HD23 ' CB ' ' A' ' 649' ' ' TYR . 3.4 mt -108.65 95.63 5.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.291 0.567 . . . . 1.0800000000000001 111.157 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.53 ' HA ' ' HA3' ' A' ' 706' ' ' GLY . 64.7 mt-30 -76.91 145.04 38.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.271 -0.877 . . . . 0.66000000000000003 110.198 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.501 ' HB2' HD13 ' A' ' 696' ' ' ILE . 48.6 t0 -47.81 113.08 0.65 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.913 0.387 . . . . 1.3400000000000001 110.511 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 92.52 38.61 5.54 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.502 -1.039 . . . . 0.29999999999999999 110.502 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.3 117.95 26.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.268 -0.466 . . . . 1.28 111.031 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -96.24 108.87 21.41 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.665 -0.494 . . . . 2.7000000000000002 109.665 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . . . . . . . . . 4.4 mt -105.5 127.67 60.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.114 0.483 . . . . 1.78 111.961 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -90.82 116.13 28.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.589 -0.732 . . . . 2.4900000000000002 109.554 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.434 ' CG2' ' CD2' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -81.59 -37.39 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 1.3700000000000001 111.258 -179.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.411 HG21 ' HB ' ' A' ' 690' ' ' ILE . 2.6 tp -155.14 131.39 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 1.3999999999999999 111.625 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -136.32 125.2 24.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.462 . . . . 0.69999999999999996 111.093 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.84 117.11 22.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.382 -0.372 . . . . 1.71 110.397 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -66.89 -46.65 74.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 3.1499999999999999 111.744 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -83.2 -40.31 19.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.349 -0.387 . . . . 2.0299999999999998 111.397 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.69 -12.25 59.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.386 -0.37 . . . . 2.0899999999999999 111.369 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 16.0 mttt 61.86 17.2 8.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.664 0.269 . . . . 3.1200000000000001 110.905 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.455 ' CZ ' ' CD1' ' A' ' 587' ' ' ILE . 2.2 t80 -78.79 104.73 9.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.864 -0.791 . . . . 1.5600000000000001 108.864 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.421 ' O ' ' CG1' ' A' ' 689' ' ' VAL . 2.3 p -118.65 121.35 66.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.14 0.495 . . . . 1.48 112.004 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.415 ' HA ' ' CB ' ' A' ' 586' ' ' SER . 2.1 mt -129.14 155.31 41.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 1.47 110.417 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.423 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 179.5 133.03 1.88 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.887 -0.673 . . . . 0.39000000000000001 112.129 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.481 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.3 m-30 -113.19 143.46 44.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.47999999999999998 110.514 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -101.29 117.04 34.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 2.52 110.375 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.481 HG13 ' CD1' ' A' ' 578' ' ' LEU . 2.2 t -84.2 119.62 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.865 -0.607 . . . . 1.1000000000000001 110.859 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.46 108.16 10.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 1.73 110.635 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.501 HD13 ' HB2' ' A' ' 674' ' ' ASP . 57.9 mt -71.27 106.77 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.587 -0.733 . . . . 1.1299999999999999 110.772 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -89.42 -47.07 8.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.207 0.527 . . . . 1.1599999999999999 109.633 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.507 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 6.0 t0 -111.25 141.86 44.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.459 -0.791 . . . . 1.4099999999999999 110.336 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 2.7 p -113.98 100.13 8.18 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.453 0.644 . . . . 1.26 109.741 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' THR . . . . . 0.423 HG21 ' CD2' ' A' ' 577' ' ' PHE . 5.9 t -76.82 70.41 3.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.311 -0.859 . . . . 2.0600000000000001 110.501 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 63.58 30.4 77.5 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.399 -0.905 . . . . 1.0900000000000001 111.622 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 699' ' ' THR . 0.3 OUTLIER -61.31 131.86 51.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.387 0.137 . . . . 2.0899999999999999 110.705 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.42 ' CE1' ' OD1' ' A' ' 646' ' ' ASP . 1.4 p90 -46.63 -29.73 1.98 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.613 0.72 . . . . 1.8500000000000001 109.823 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.67 ' ND2' ' H ' ' A' ' 706' ' ' GLY . 0.4 OUTLIER -155.43 -52.09 0.09 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.59 -1.186 . . . . 1.5600000000000001 108.121 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 704' ' ' ASN . 1.3 pt-20 146.92 -36.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 113.986 -1.461 . . . . 2.3300000000000001 107.945 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.67 ' H ' ' ND2' ' A' ' 704' ' ' ASN . . . 140.42 80.84 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.486 -1.234 . . . . 1.6899999999999999 111.853 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.495 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.5 OUTLIER -106.95 -10.21 16.04 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 122.404 -0.468 . . . . 2.8399999999999999 111.675 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 113.89 8.63 17.67 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.697 -0.764 . . . . 2.9900000000000002 112.931 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 7.6 ptp 46.36 40.92 8.51 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.227 0.454 . . . . 3.2799999999999998 112.227 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 712' ' ' GLU . 0.3 OUTLIER 45.69 -154.68 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.556 -0.293 . . . . 6.5599999999999996 111.709 179.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 710' ' ' LEU . 2.4 mm-40 14.08 -76.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.064 0.946 . . . . 9.0899999999999999 112.37 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' A' ' 710' ' ' LEU . 2.0 mm-40 -65.23 96.84 0.23 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.424 -0.584 . . . . 5.8600000000000003 109.424 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -93.66 100.67 12.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.632 -0.713 . . . . 5.0499999999999998 111.761 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.484 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.1 OUTLIER 47.15 87.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.707 -0.679 . . . . 2.1099999999999999 112.469 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.4 141.24 45.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.965 -0.561 . . . . 1.27 109.93 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 95.7 t -90.99 130.17 40.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.932 0.396 . . . . 1.8700000000000001 111.337 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 5.2 mp -108.57 168.43 9.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.954 -0.566 . . . . 1.5600000000000001 110.725 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.06 150.44 20.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 2.9900000000000002 110.925 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -89.87 154.37 19.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.945 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.2 p -126.07 -174.06 3.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 1.28 111.313 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.51 -31.94 62.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 1.2 111.213 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -57.73 -51.94 67.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 2.1099999999999999 110.823 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.16 -48.48 67.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 1.9099999999999999 110.781 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -60.5 -32.76 71.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.473 . . . . 3.0600000000000001 111.028 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -63.87 -39.14 93.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 1.8300000000000001 111.172 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 3.3 mt -62.18 -44.3 96.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.395 -0.366 . . . . 1.2 110.962 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.84 -28.48 27.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 1.3899999999999999 110.98 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -56.33 -34.67 66.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 2.9100000000000001 110.9 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -98.3 28.84 3.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 3.1499999999999999 110.828 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.419 HD11 ' CG ' ' A' ' 602' ' ' PHE . 5.6 tt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.198 -0.906 . . . . 1.5 110.744 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.839 0.352 . . . . 6.3200000000000003 111.171 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' P' P ' 600' ' ' VAL . . . . . . . . . . . . . 10.9 p -126.09 153.71 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 4.2999999999999998 111.133 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 601' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -166.59 44.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 3.8599999999999999 110.872 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 602' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.24 156.46 47.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 3.0800000000000001 110.936 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -75.99 76.11 2.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 2.02 110.813 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -63.99 115.55 5.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 2.4199999999999999 110.928 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 606' ' ' LEU . . . . . . . . . . . . . 13.0 mt -79.24 153.32 76.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 1.51 110.875 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 C--O 1.25 1.091 0 C-N-CA 122.536 2.157 . . . . 3.2200000000000002 112.294 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.48 -0.248 . . . . 4.45 112.48 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -93.82 10.58 32.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.523 0.201 . . . . 3.64 111.263 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 138.25 4.34 1.75 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.483 -0.865 . . . . 0.94 113.081 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.422 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 6.3 tmm_? -108.24 137.12 46.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.98 0.39 . . . . 1.75 111.068 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.716 ' CE1' HG21 ' A' ' 647' ' ' ILE . 2.4 t80 -122.56 -55.52 1.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.104 -0.498 . . . . 1.02 111.254 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.961 HD11 HG13 ' A' ' 694' ' ' VAL . 11.6 tp -113.0 142.98 45.08 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.942 0.401 . . . . 1.11 111.169 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 10.3 m -120.11 114.8 22.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.982 -0.554 . . . . 0.26 111.437 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.584 HD11 HD12 ' A' ' 625' ' ' ILE . 1.4 mp -105.36 109.08 20.93 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 106.889 -1.523 . . . . 1.04 106.889 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 12.4 ptpt -112.18 99.75 47.26 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 114.698 1.37 . . . . 1.59 114.698 -176.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 0.593 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.8 Cg_exo -47.24 99.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 121.826 1.684 . . . . 0.2 109.513 176.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.624 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.1 OUTLIER -74.65 157.26 86.19 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.701 1.0 . . . . 1.18 113.701 -176.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 584' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.88 -25.75 12.65 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.583 2.855 . . . . 0.52 112.934 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -61.95 -26.76 68.39 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.088 -0.708 . . . . 2.01 109.088 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.435 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 2.9 t -95.82 154.08 17.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.998 -1.001 . . . . 0.88 109.866 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.461 HD13 ' CE1' ' A' ' 688' ' ' PHE . 20.2 pt -55.91 -12.81 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.719 0.295 . . . . 1.24 111.082 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.509 HD13 HG23 ' A' ' 613' ' ' ILE . 17.9 mt -108.48 124.42 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.398 -0.364 . . . . 0.83 111.77 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.38 56.41 0.63 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.151 0.501 . . . . 1.32 110.075 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 0.593 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 13.8 mt-10 -124.81 171.6 10.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.677 -0.692 . . . . 2.05 111.378 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.23 126.38 40.81 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.994 0.426 . . . . 0.4 110.866 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.76 HD22 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.4 137.13 51.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.916 -0.584 . . . . 2.08 109.982 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.422 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.2 mp0 -124.02 114.72 20.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.084 -0.246 . . . . 1.75 111.611 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.051 HD11 HD12 ' A' ' 625' ' ' ILE . 30.2 mt -71.54 109.66 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 120.789 0.328 . . . . 0.38 110.536 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.2 mp0 -65.92 107.9 2.0 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.873 -0.788 . . . . 1.96 108.873 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.466 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -42.5 -31.01 0.39 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.06 0.457 . . . . 1.2 110.996 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -66.47 -23.19 71.84 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.828 -0.701 . . . . 0.78 113.145 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.589 HG11 ' OD1' ' A' ' 610' ' ' ASN . 76.1 t -101.32 119.41 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 117.594 0.697 . . . . 0.48 111.616 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 12.4 t30 -139.13 123.47 11.33 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.902 -0.59 . . . . 0.7 109.685 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.715 ' HD3' HD22 ' A' ' 726' ' ' LEU . 51.8 Cg_endo -90.04 160.51 34.24 Favored 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 124.555 -1.019 . . . . 0.36 112.13 0.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.61 ' CD2' HG12 ' A' ' 594' ' ' ILE . 2.6 t80 -91.84 114.27 26.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.038 0.447 . . . . 0.22 109.96 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.507 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 19.6 m-85 -92.14 137.91 31.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.742 -0.663 . . . . 0.42 111.562 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.769 HD12 ' HA ' ' A' ' 624' ' ' PHE . 3.6 mp -125.79 146.09 32.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.652 -0.703 . . . . 0.28 110.743 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 161.05 -172.51 37.33 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.202 -0.999 . . . . 0.19 113.511 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.496 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -67.26 -53.84 26.33 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.816 0.341 . . . . 1.02 111.798 -179.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.482 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.45 127.89 33.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.77 111.221 -179.054 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -54.49 -19.35 5.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.882 -0.599 . . . . 2.53 111.08 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -53.76 -29.68 41.01 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.051 0.453 . . . . 1.44 110.397 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.414 ' SG ' HG22 ' A' ' 621' ' ' VAL . 61.5 m -73.85 133.6 43.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.708 -0.678 . . . . 0.39 110.567 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.589 ' OD1' HG11 ' A' ' 598' ' ' VAL . 0.6 OUTLIER -47.77 -28.0 2.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.986 0.422 . . . . 1.43 110.461 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.763 ' SG ' HG23 ' A' ' 603' ' ' ILE . 43.3 t -111.94 142.3 44.51 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.278 -0.638 . . . . 0.17 109.278 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.33 105.25 14.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.045 0.757 . . . . 1.74 113.045 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.69 HD11 HD21 ' A' ' 592' ' ' LEU . 37.5 mm -138.88 109.39 4.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.108 -0.951 . . . . 0.31 109.027 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.67 106.39 16.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.489 0.662 . . . . 2.24 112.395 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.636 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.3 t0 -130.27 108.06 9.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.795 -1.093 . . . . 1.47 108.64 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -40.18 -28.09 0.05 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.758 0.651 . . . . 1.46 112.758 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.402 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 0.1 OUTLIER -71.16 -40.32 71.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.066 0.395 . . . . 2.03 112.066 -179.409 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.636 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -89.4 159.25 17.4 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.971 0.415 . . . . 1.19 111.726 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 9.5 m -79.12 168.46 19.59 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.926 -0.579 . . . . 1.31 111.435 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.485 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 2.3 mpt_? -50.07 -35.94 27.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.232 0.539 . . . . 2.07 110.449 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.414 HG22 ' SG ' ' A' ' 609' ' ' CYS . 22.6 t -124.83 64.55 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.337 -0.847 . . . . 1.09 109.461 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.564 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 10.3 t60 -49.66 -44.37 47.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.476 -0.783 . . . . 0.45 111.956 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.1 p -165.67 159.74 16.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.039 0.447 . . . . 0.45 111.784 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.769 ' HA ' HD12 ' A' ' 603' ' ' ILE . 52.2 p90 -143.65 147.35 34.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.736 -0.665 . . . . 1.03 110.827 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 1.051 HD12 HD11 ' A' ' 594' ' ' ILE . 65.6 mt -102.27 140.05 21.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.273 -0.422 . . . . 0.73 109.871 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.54 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.6 t80 -132.7 134.42 44.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.214 -0.448 . . . . 0.38 110.856 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.642 ' NZ ' HG21 ' A' ' 700' ' ' THR . 22.6 ttmt -97.72 134.98 40.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.127 -0.488 . . . . 1.14 110.207 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.451 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.23 158.15 45.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 1.98 112.081 -178.656 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.94 112.42 14.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.726 -0.67 . . . . 2.01 110.307 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 644' ' ' LEU . 7.1 t60 -72.66 130.77 41.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.701 -0.682 . . . . 0.93 111.119 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -153.25 131.43 11.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 1.39 111.133 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.583 HG21 ' HG2' ' A' ' 640' ' ' PRO . 31.3 m -92.86 -179.12 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 2.16 111.094 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -70.03 -72.31 0.89 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.759 . . . . 2.78 112.585 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -128.42 178.46 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 5.17 110.87 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.43 44.08 2.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 2.97 110.878 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 87.5 mtp -59.95 119.87 8.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 5.48 110.941 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 68.42 -69.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 7.33 110.958 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -79.67 142.93 35.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 5.04 110.846 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.8 m -112.3 96.33 34.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 3.45 110.909 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.583 ' HG2' HG21 ' A' ' 632' ' ' VAL . 27.9 Cg_exo -61.93 -154.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.544 2.163 . . . . 2.25 112.088 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.629 ' HB1' ' CD1' ' A' ' 644' ' ' LEU . . . -62.92 -16.61 59.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 1.87 111.603 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 78.75 -61.34 0.36 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.549 -0.296 . . . . 2.99 110.972 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 178.18 74.24 0.06 OUTLIER Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.354 -0.926 . . . . 0.74 113.142 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.629 ' CD1' ' HB1' ' A' ' 641' ' ' ALA . 1.6 mp -108.26 -162.12 0.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.321 -0.252 . . . . 1.35 110.321 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.457 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.5 OUTLIER -116.57 147.94 41.36 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.113 0.482 . . . . 1.58 112.243 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.42 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -135.03 139.1 44.54 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.527 -0.761 . . . . 1.3 110.124 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.756 HD13 HD13 ' A' ' 578' ' ' LEU . 3.6 pt -88.95 130.38 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.36 0.6 . . . . 0.38 111.589 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.889 ' CH2' HD22 ' A' ' 671' ' ' LEU . 96.3 m95 -111.31 143.66 41.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.192 -0.913 . . . . 0.31 111.075 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.609 ' CE2' HG21 ' A' ' 678' ' ' ILE . 4.4 t80 -107.98 117.15 33.38 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.579 -0.526 . . . . 0.49 109.579 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.41 ' N ' ' O ' ' A' ' 624' ' ' PHE . 14.3 m -105.32 138.35 41.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.247 -0.433 . . . . 0.7 111.566 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 57.6 t60 -119.59 133.29 55.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.102 -0.499 . . . . 0.26 111.097 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 7.2 p -129.6 6.46 5.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.863 -0.608 . . . . 0.46 111.374 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.41 150.07 36.26 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.835 -0.698 . . . . 0.34 112.669 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 6.4 t -71.59 -38.13 70.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.144 0.497 . . . . 1.03 111.419 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.622 ' O ' HG13 ' A' ' 656' ' ' VAL . 2.6 m-80 -68.52 -3.88 13.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.619 -0.719 . . . . 1.9 112.267 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.3 OUTLIER 54.79 124.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.207 0.527 . . . . 0.98 111.575 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 75.4 p -87.7 166.47 14.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.794 -0.639 . . . . 1.24 110.301 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -129.75 119.57 23.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.808 0.337 . . . . 0.71 110.692 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.707 HD23 ' CD2' ' A' ' 670' ' ' PHE . 0.7 OUTLIER -101.25 111.14 23.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 0.81 111.514 -179.514 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.432 ' N ' HD12 ' A' ' 659' ' ' LEU . 24.7 t-20 55.72 -82.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 1.94 111.163 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 659' ' ' LEU . 5.3 m-20 -136.5 7.57 3.06 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.826 0.306 . . . . 1.93 111.826 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.726 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.7 OUTLIER -110.38 141.14 43.83 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.878 0.371 . . . . 1.7 110.995 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.408 ' O ' HG21 ' A' ' 716' ' ' VAL . 7.2 ttm180 -79.79 141.42 36.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 2.66 111.153 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.576 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 44.1 mmm -116.24 100.78 8.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.77 110.921 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.449 HG12 HG21 ' A' ' 668' ' ' THR . 33.0 pt -87.88 140.97 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.6 110.762 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -39.4 101.85 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.269 -0.423 . . . . 0.79 111.68 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 109.64 37.22 1.93 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.909 -0.663 . . . . 0.32 112.456 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.449 HG21 HG12 ' A' ' 665' ' ' ILE . 1.0 OUTLIER -123.97 160.31 27.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.961 0.41 . . . . 0.59 111.344 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.449 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.3 ttpm? -128.05 149.08 50.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.848 -0.615 . . . . 0.64 110.141 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.707 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.87 143.63 27.55 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.398 0.518 . . . . 0.95 112.398 -178.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.889 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.41 138.63 53.74 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.191 -0.459 . . . . 1.36 109.778 178.446 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.833 HD13 HG21 ' A' ' 694' ' ' VAL . 3.4 mt -108.65 95.63 5.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.291 0.567 . . . . 0.42 111.157 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.538 ' HA ' ' HA3' ' A' ' 706' ' ' GLY . 23.9 mt-30 -76.91 145.04 38.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.271 -0.877 . . . . 0.44 110.198 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.559 ' HB2' HD12 ' A' ' 696' ' ' ILE . 48.6 t0 -47.81 113.08 0.65 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.913 0.387 . . . . 1.34 110.511 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 92.52 38.61 5.54 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.502 -1.039 . . . . 0.26 110.502 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.401 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.1 OUTLIER -87.3 117.95 26.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.268 -0.466 . . . . 1.28 111.031 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -96.24 108.87 21.41 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.665 -0.494 . . . . 2.7 109.665 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.699 HG12 HD13 ' A' ' 659' ' ' LEU . 4.4 mt -105.5 127.67 60.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.114 0.483 . . . . 1.19 111.961 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -90.82 116.13 28.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.589 -0.732 . . . . 1.99 109.554 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.547 ' CG2' HD23 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -81.59 -37.39 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.59 111.258 -179.145 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.531 HG22 ' HB ' ' A' ' 690' ' ' ILE . 2.6 tp -155.14 131.39 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 0.64 111.625 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -136.32 125.2 24.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.462 . . . . 0.62 111.093 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.674 ' CG ' HD13 ' P' ' 606' ' ' LEU . 0.6 OUTLIER -125.84 117.11 22.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.382 -0.372 . . . . 1.71 110.397 179.159 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -66.89 -46.65 74.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 2.73 111.744 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -83.2 -40.31 19.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.349 -0.387 . . . . 1.8 111.397 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.69 -12.25 59.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.386 -0.37 . . . . 1.6 111.369 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 16.0 mttt 61.86 17.2 8.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.664 0.269 . . . . 2.63 110.905 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.461 ' CE1' HD13 ' A' ' 587' ' ' ILE . 2.2 t80 -78.79 104.73 9.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.864 -0.791 . . . . 1.09 108.864 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.457 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.3 p -118.65 121.35 66.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.14 0.495 . . . . 0.83 112.004 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.531 ' HB ' HG22 ' A' ' 681' ' ' ILE . 2.1 mt -129.14 155.31 41.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.77 110.417 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.435 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 179.5 133.03 1.88 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.887 -0.673 . . . . 0.23 112.129 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.475 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.3 m-30 -113.19 143.46 44.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.37 110.514 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.624 ' HB2' HD22 ' A' ' 583' ' ' LEU . 3.7 tttt -101.29 117.04 34.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 2.05 110.375 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.961 HG13 HD11 ' A' ' 578' ' ' LEU . 2.2 t -84.2 119.62 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.865 -0.607 . . . . 0.27 110.859 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.46 108.16 10.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 1.73 110.635 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 674' ' ' ASP . 57.9 mt -71.27 106.77 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.587 -0.733 . . . . 0.39 110.772 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -89.42 -47.07 8.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.207 0.527 . . . . 1.16 109.633 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.507 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 6.0 t0 -111.25 141.86 44.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.459 -0.791 . . . . 1.41 110.336 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 2.7 p -113.98 100.13 8.18 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.453 0.644 . . . . 0.8 109.741 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.642 HG21 ' NZ ' ' A' ' 627' ' ' LYS . 5.9 t -76.82 70.41 3.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.311 -0.859 . . . . 1.56 110.501 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.595 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 63.58 30.4 77.5 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.399 -0.905 . . . . 0.98 111.622 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.696 HD12 ' CA ' ' A' ' 705' ' ' GLU . 0.3 OUTLIER -61.31 131.86 51.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.387 0.137 . . . . 1.49 110.705 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.627 ' HA ' HD13 ' A' ' 644' ' ' LEU . 1.4 p90 -46.63 -29.73 1.98 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.613 0.72 . . . . 1.85 109.823 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.673 HD22 HD23 ' A' ' 707' ' ' LEU . 0.2 OUTLIER -155.43 -52.09 0.09 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.59 -1.186 . . . . 1.56 108.121 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.696 ' CA ' HD12 ' A' ' 702' ' ' LEU . 1.3 pt-20 146.92 -36.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 113.986 -1.461 . . . . 2.33 107.945 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 673' ' ' GLN . . . 140.42 80.84 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.486 -1.234 . . . . 1.69 111.853 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.673 HD23 HD22 ' A' ' 704' ' ' ASN . 0.5 OUTLIER -106.95 -10.21 16.04 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 122.404 -0.468 . . . . 2.43 111.675 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 113.89 8.63 17.67 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.697 -0.764 . . . . 2.99 112.931 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 7.6 ptp 46.36 40.92 8.51 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.227 0.454 . . . . 3.22 112.227 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 712' ' ' GLU . 0.3 OUTLIER 45.69 -154.68 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.556 -0.293 . . . . 6.1 111.709 179.077 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 711' ' ' GLN . . . . . 0.525 ' H ' HD12 ' A' ' 710' ' ' LEU . 2.4 mm-40 14.08 -76.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.064 0.946 . . . . 8.51 112.37 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' A' ' 710' ' ' LEU . 2.0 mm-40 -65.23 96.84 0.23 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.424 -0.584 . . . . 5.49 109.424 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -93.66 100.67 12.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.632 -0.713 . . . . 4.53 111.761 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.492 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.1 OUTLIER 47.15 87.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.707 -0.679 . . . . 1.42 112.469 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.4 141.24 45.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.965 -0.561 . . . . 0.66 109.93 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.726 HG23 ' CG ' ' A' ' 662' ' ' ASN . 95.7 t -90.99 130.17 40.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.932 0.396 . . . . 1.24 111.337 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.448 HD12 ' N ' ' A' ' 717' ' ' LEU . 5.2 mp -108.57 168.43 9.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.954 -0.566 . . . . 0.97 110.725 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.06 150.44 20.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 2.52 110.925 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -89.87 154.37 19.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.75 110.945 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.2 p -126.07 -174.06 3.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.72 111.313 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.51 -31.94 62.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.54 111.213 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -57.73 -51.94 67.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 2.11 110.823 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.716 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.4 OUTLIER -67.16 -48.48 67.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 1.91 110.781 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.465 ' O ' HG12 ' A' ' 727' ' ' VAL . 27.4 ttmt -60.5 -32.76 71.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.473 . . . . 2.55 111.028 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -63.87 -39.14 93.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 1.83 111.172 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.716 HD12 ' HA ' ' A' ' 723' ' ' GLU . 3.3 mt -62.18 -44.3 96.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.395 -0.366 . . . . 0.47 110.962 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 724' ' ' LYS . 10.4 p -72.84 -28.48 27.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.74 110.98 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -56.33 -34.67 66.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 2.43 110.9 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -98.3 28.84 3.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 2.71 110.828 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.476 HD12 ' CG ' ' A' ' 602' ' ' PHE . 5.6 tt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.198 -0.906 . . . . 1.5 110.744 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.839 0.352 . . . . 6.32 111.171 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' P' P ' 600' ' ' VAL . . . . . 0.401 HG22 ' N ' ' P' ' 601' ' ' GLU . 10.9 p -126.09 153.71 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 3.92 111.133 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 601' ' ' GLU . . . . . 0.468 ' C ' HD12 ' P' ' 602' ' ' LEU . 8.7 mt-10 -166.59 44.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 3.86 110.872 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 602' ' ' LEU . . . . . 0.468 HD12 ' C ' ' P' ' 601' ' ' GLU . 5.3 mp -139.24 156.46 47.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 2.55 110.936 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -75.99 76.11 2.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 2.02 110.813 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -63.99 115.55 5.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 2.42 110.928 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 606' ' ' LEU . . . . . 0.674 HD13 ' CG ' ' A' ' 683' ' ' ASP . 13.0 mt -79.24 153.32 76.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 1.38 110.875 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 C--O 1.25 1.091 0 C-N-CA 122.536 2.157 . . . . 2.72 112.294 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.48 -0.248 . . . . 4.45 112.48 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -93.82 10.58 32.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.523 0.201 . . . . 3.64 111.263 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 138.25 4.34 1.75 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.483 -0.865 . . . . 0.94 113.081 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.422 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 6.3 tmm_? -108.24 137.12 46.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.98 0.39 . . . . 1.75 111.068 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.716 ' CE1' HG21 ' A' ' 647' ' ' ILE . 2.4 t80 -122.56 -55.52 1.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.104 -0.498 . . . . 1.02 111.254 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.961 HD11 HG13 ' A' ' 694' ' ' VAL . 11.6 tp -113.0 142.98 45.08 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.942 0.401 . . . . 1.11 111.169 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 593' ' ' GLU . 10.3 m -120.11 114.8 22.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.982 -0.554 . . . . 0.26 111.437 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.584 HD11 HD12 ' A' ' 625' ' ' ILE . 1.4 mp -105.36 109.08 20.93 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 106.889 -1.523 . . . . 1.04 106.889 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 591' ' ' SER . 12.4 ptpt -112.18 99.75 47.26 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 114.698 1.37 . . . . 1.59 114.698 -176.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 0.593 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 31.8 Cg_exo -47.24 99.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 121.826 1.684 . . . . 0.2 109.513 176.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.624 HD22 ' HB2' ' A' ' 693' ' ' LYS . 0.1 OUTLIER -74.65 157.26 86.19 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 113.701 1.0 . . . . 1.18 113.701 -176.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.429 ' HA ' ' NE2' ' A' ' 589' ' ' GLN . 76.3 Cg_exo -49.88 -25.75 12.65 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.583 2.855 . . . . 0.52 112.934 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -61.95 -26.76 68.39 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.088 -0.708 . . . . 2.01 109.088 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.435 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 2.9 t -95.82 154.08 17.41 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.998 -1.001 . . . . 0.88 109.866 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.461 HD13 ' CE1' ' A' ' 688' ' ' PHE . 20.2 pt -55.91 -12.81 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.719 0.295 . . . . 1.24 111.082 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.509 HD13 HG23 ' A' ' 613' ' ' ILE . 17.9 mt -108.48 124.42 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.398 -0.364 . . . . 0.83 111.77 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.429 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -110.38 56.41 0.63 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.151 0.501 . . . . 1.32 110.075 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 0.593 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 13.8 mt-10 -124.81 171.6 10.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.677 -0.692 . . . . 2.05 111.378 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -128.23 126.38 40.81 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.994 0.426 . . . . 0.4 110.866 178.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.76 HD22 ' SG ' ' A' ' 611' ' ' CYS . 0.1 OUTLIER -112.4 137.13 51.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.916 -0.584 . . . . 2.08 109.982 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.422 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.2 mp0 -124.02 114.72 20.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 121.084 -0.246 . . . . 1.75 111.611 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.051 HD11 HD12 ' A' ' 625' ' ' ILE . 30.2 mt -71.54 109.66 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 120.789 0.328 . . . . 0.38 110.536 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 0.8 OUTLIER -65.92 107.9 2.0 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.873 -0.788 . . . . 1.96 108.873 178.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.466 ' HB3' ' HB2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -42.5 -31.01 0.39 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.06 0.457 . . . . 1.2 110.996 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' A' ' 596' ' ' GLN . . . -66.47 -23.19 71.84 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.828 -0.701 . . . . 0.78 113.145 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.589 HG11 ' OD1' ' A' ' 610' ' ' ASN . 76.1 t -101.32 119.41 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 117.594 0.697 . . . . 0.48 111.616 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 12.4 t30 -139.13 123.47 11.33 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.902 -0.59 . . . . 0.7 109.685 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.715 ' HD3' HD22 ' A' ' 726' ' ' LEU . 51.8 Cg_endo -90.04 160.51 34.24 Favored 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 124.555 -1.019 . . . . 0.36 112.13 0.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.61 ' CD2' HG12 ' A' ' 594' ' ' ILE . 2.6 t80 -91.84 114.27 26.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.038 0.447 . . . . 0.22 109.96 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.507 ' HA ' ' CB ' ' A' ' 624' ' ' PHE . 19.6 m-85 -92.14 137.91 31.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.742 -0.663 . . . . 0.42 111.562 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.769 HD12 ' HA ' ' A' ' 624' ' ' PHE . 3.6 mp -125.79 146.09 32.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.652 -0.703 . . . . 0.28 110.743 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 161.05 -172.51 37.33 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.202 -0.999 . . . . 0.19 113.511 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.496 ' HG2' ' CD1' ' A' ' 618' ' ' LEU . 0.4 OUTLIER -67.26 -53.84 26.33 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.816 0.341 . . . . 1.02 111.798 -179.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.482 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -60.45 127.89 33.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.77 111.221 -179.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -54.49 -19.35 5.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.882 -0.599 . . . . 2.53 111.08 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -53.76 -29.68 41.01 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.051 0.453 . . . . 1.44 110.397 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.414 ' SG ' HG22 ' A' ' 621' ' ' VAL . 61.5 m -73.85 133.6 43.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.708 -0.678 . . . . 0.39 110.567 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.589 ' OD1' HG11 ' A' ' 598' ' ' VAL . 0.6 OUTLIER -47.77 -28.0 2.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.986 0.422 . . . . 1.43 110.461 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.763 ' SG ' HG23 ' A' ' 603' ' ' ILE . 43.3 t -111.94 142.3 44.51 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.278 -0.638 . . . . 0.17 109.278 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.33 105.25 14.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.045 0.757 . . . . 1.74 113.045 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.69 HD11 HD21 ' A' ' 592' ' ' LEU . 37.5 mm -138.88 109.39 4.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.108 -0.951 . . . . 0.31 109.027 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.67 106.39 16.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.489 0.662 . . . . 2.24 112.395 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.636 ' H ' HD11 ' A' ' 618' ' ' LEU . 1.3 t0 -130.27 108.06 9.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.795 -1.093 . . . . 1.47 108.64 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -40.18 -28.09 0.05 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.758 0.651 . . . . 1.46 112.758 -178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.402 ' HB3' ' CD1' ' A' ' 681' ' ' ILE . 0.1 OUTLIER -71.16 -40.32 71.38 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.066 0.395 . . . . 2.03 112.066 -179.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.636 HD11 ' H ' ' A' ' 615' ' ' ASP . 0.9 OUTLIER -89.4 159.25 17.4 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.971 0.415 . . . . 1.19 111.726 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 9.5 m -79.12 168.46 19.59 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.926 -0.579 . . . . 1.31 111.435 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.485 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 2.3 mpt_? -50.07 -35.94 27.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.232 0.539 . . . . 2.07 110.449 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.414 HG22 ' SG ' ' A' ' 609' ' ' CYS . 22.6 t -124.83 64.55 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.337 -0.847 . . . . 1.09 109.461 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.564 ' CG ' ' HB2' ' A' ' 618' ' ' LEU . 10.3 t60 -49.66 -44.37 47.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.476 -0.783 . . . . 0.45 111.956 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 6.1 p -165.67 159.74 16.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.039 0.447 . . . . 0.45 111.784 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.769 ' HA ' HD12 ' A' ' 603' ' ' ILE . 52.2 p90 -143.65 147.35 34.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.736 -0.665 . . . . 1.03 110.827 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 1.051 HD12 HD11 ' A' ' 594' ' ' ILE . 65.6 mt -102.27 140.05 21.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.273 -0.422 . . . . 0.73 109.871 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.54 ' HB2' ' HB3' ' A' ' 600' ' ' PRO . 4.6 t80 -132.7 134.42 44.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.214 -0.448 . . . . 0.38 110.856 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.642 ' NZ ' HG21 ' A' ' 700' ' ' THR . 22.6 ttmt -97.72 134.98 40.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.127 -0.488 . . . . 1.14 110.207 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.451 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.23 158.15 45.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 1.98 112.081 -178.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.94 112.42 14.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.726 -0.67 . . . . 2.01 110.307 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 644' ' ' LEU . 7.1 t60 -72.66 130.77 41.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.701 -0.682 . . . . 0.93 111.119 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -153.25 131.43 11.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 1.39 111.133 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.583 HG21 ' HG2' ' A' ' 640' ' ' PRO . 31.3 m -92.86 -179.12 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 2.16 111.094 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -70.03 -72.31 0.89 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.759 . . . . 2.78 112.585 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -128.42 178.46 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 5.17 110.87 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.43 44.08 2.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.477 . . . . 2.97 110.878 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 87.5 mtp -59.95 119.87 8.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 5.48 110.941 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 68.42 -69.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 7.33 110.958 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -79.67 142.93 35.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 5.04 110.846 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 1.8 m -112.3 96.33 34.9 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 3.45 110.909 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.583 ' HG2' HG21 ' A' ' 632' ' ' VAL . 27.9 Cg_exo -61.93 -154.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.544 2.163 . . . . 2.25 112.088 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.629 ' HB1' ' CD1' ' A' ' 644' ' ' LEU . . . -62.92 -16.61 59.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 1.87 111.603 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 78.75 -61.34 0.36 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.549 -0.296 . . . . 2.99 110.972 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 178.18 74.24 0.06 OUTLIER Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.354 -0.926 . . . . 0.74 113.142 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.629 ' CD1' ' HB1' ' A' ' 641' ' ' ALA . 1.6 mp -108.26 -162.12 0.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.321 -0.252 . . . . 1.35 110.321 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.457 ' O ' HD13 ' A' ' 702' ' ' LEU . 0.5 OUTLIER -116.57 147.94 41.36 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.113 0.482 . . . . 1.58 112.243 -178.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.42 ' OD1' ' CE1' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -135.03 139.1 44.54 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.527 -0.761 . . . . 1.3 110.124 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.756 HD13 HD13 ' A' ' 578' ' ' LEU . 3.6 pt -88.95 130.38 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.36 0.6 . . . . 0.38 111.589 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.889 ' CH2' HD22 ' A' ' 671' ' ' LEU . 96.3 m95 -111.31 143.66 41.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.192 -0.913 . . . . 0.31 111.075 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.609 ' CE2' HG21 ' A' ' 678' ' ' ILE . 4.4 t80 -107.98 117.15 33.38 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.579 -0.526 . . . . 0.49 109.579 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.41 ' N ' ' O ' ' A' ' 624' ' ' PHE . 14.3 m -105.32 138.35 41.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.247 -0.433 . . . . 0.7 111.566 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 657' ' ' SER . 57.6 t60 -119.59 133.29 55.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.102 -0.499 . . . . 0.26 111.097 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . . . . . . . . . 7.2 p -129.6 6.46 5.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.863 -0.608 . . . . 0.46 111.374 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 622' ' ' HIS . . . -77.41 150.07 36.26 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.835 -0.698 . . . . 0.34 112.669 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 6.4 t -71.59 -38.13 70.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.144 0.497 . . . . 1.03 111.419 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.622 ' O ' HG13 ' A' ' 656' ' ' VAL . 2.6 m-80 -68.52 -3.88 13.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.619 -0.719 . . . . 1.9 112.267 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 655' ' ' ASN . 0.3 OUTLIER 54.79 124.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.207 0.527 . . . . 0.98 111.575 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 651' ' ' HIS . 75.4 p -87.7 166.47 14.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.794 -0.639 . . . . 1.24 110.301 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -129.75 119.57 23.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.808 0.337 . . . . 0.71 110.692 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.707 HD23 ' CD2' ' A' ' 670' ' ' PHE . 0.7 OUTLIER -101.25 111.14 23.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 0.81 111.514 -179.514 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.432 ' N ' HD12 ' A' ' 659' ' ' LEU . 24.7 t-20 55.72 -82.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 1.94 111.163 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 659' ' ' LEU . 5.3 m-20 -136.5 7.57 3.06 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.826 0.306 . . . . 1.93 111.826 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.726 ' CG ' HG23 ' A' ' 716' ' ' VAL . 0.7 OUTLIER -110.38 141.14 43.83 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.878 0.371 . . . . 1.7 110.995 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.408 ' O ' HG21 ' A' ' 716' ' ' VAL . 7.2 ttm180 -79.79 141.42 36.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 2.66 111.153 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.576 ' HE1' ' HB2' ' A' ' 670' ' ' PHE . 44.1 mmm -116.24 100.78 8.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.77 110.921 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.449 HG12 HG21 ' A' ' 668' ' ' THR . 33.0 pt -87.88 140.97 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.6 110.762 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -39.4 101.85 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.269 -0.423 . . . . 0.79 111.68 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 109.64 37.22 1.93 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.909 -0.663 . . . . 0.32 112.456 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.449 HG21 HG12 ' A' ' 665' ' ' ILE . 1.0 OUTLIER -123.97 160.31 27.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.961 0.41 . . . . 0.59 111.344 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.449 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 5.3 ttpm? -128.05 149.08 50.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.848 -0.615 . . . . 0.64 110.141 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.707 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.3 OUTLIER -147.87 143.63 27.55 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.398 0.518 . . . . 0.95 112.398 -178.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.889 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.41 138.63 53.74 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.191 -0.459 . . . . 1.36 109.778 178.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.833 HD13 HG21 ' A' ' 694' ' ' VAL . 3.4 mt -108.65 95.63 5.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.291 0.567 . . . . 0.42 111.157 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.538 ' HA ' ' HA3' ' A' ' 706' ' ' GLY . 64.7 mt-30 -76.91 145.04 38.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.271 -0.877 . . . . 0.44 110.198 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.559 ' HB2' HD12 ' A' ' 696' ' ' ILE . 48.6 t0 -47.81 113.08 0.65 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.913 0.387 . . . . 1.34 110.511 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 92.52 38.61 5.54 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.502 -1.039 . . . . 0.26 110.502 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.401 ' O ' ' HB ' ' A' ' 694' ' ' VAL . 0.1 OUTLIER -87.3 117.95 26.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.268 -0.466 . . . . 1.28 111.031 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -96.24 108.87 21.41 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.665 -0.494 . . . . 2.7 109.665 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.699 HG12 HD13 ' A' ' 659' ' ' LEU . 4.4 mt -105.5 127.67 60.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.114 0.483 . . . . 1.19 111.961 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -90.82 116.13 28.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.589 -0.732 . . . . 1.99 109.554 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.547 ' CG2' HD23 ' A' ' 618' ' ' LEU . 0.4 OUTLIER -81.59 -37.39 15.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.59 111.258 -179.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.531 HG22 ' HB ' ' A' ' 690' ' ' ILE . 2.6 tp -155.14 131.39 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 0.64 111.625 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -136.32 125.2 24.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.462 . . . . 0.62 111.093 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.674 ' CG ' HD13 ' P' ' 606' ' ' LEU . 0.6 OUTLIER -125.84 117.11 22.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.382 -0.372 . . . . 1.71 110.397 179.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -66.89 -46.65 74.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 2.73 111.744 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -83.2 -40.31 19.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.349 -0.387 . . . . 1.8 111.397 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.69 -12.25 59.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.386 -0.37 . . . . 1.6 111.369 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 16.0 mttt 61.86 17.2 8.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.664 0.269 . . . . 2.63 110.905 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.461 ' CE1' HD13 ' A' ' 587' ' ' ILE . 2.2 t80 -78.79 104.73 9.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.864 -0.791 . . . . 1.09 108.864 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.457 ' O ' HG13 ' A' ' 689' ' ' VAL . 2.3 p -118.65 121.35 66.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.14 0.495 . . . . 0.83 112.004 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.531 ' HB ' HG22 ' A' ' 681' ' ' ILE . 2.1 mt -129.14 155.31 41.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.77 110.417 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.435 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . 179.5 133.03 1.88 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.887 -0.673 . . . . 0.23 112.129 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.475 ' CE1' ' HG3' ' A' ' 582' ' ' PRO . 13.3 m-30 -113.19 143.46 44.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.743 0.306 . . . . 0.37 110.514 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.624 ' HB2' HD22 ' A' ' 583' ' ' LEU . 3.7 tttt -101.29 117.04 34.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.232 -0.44 . . . . 2.05 110.375 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.961 HG13 HD11 ' A' ' 578' ' ' LEU . 2.2 t -84.2 119.62 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.865 -0.607 . . . . 0.27 110.859 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.46 108.16 10.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 1.73 110.635 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 674' ' ' ASP . 57.9 mt -71.27 106.77 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.587 -0.733 . . . . 0.39 110.772 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -89.42 -47.07 8.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.207 0.527 . . . . 1.16 109.633 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.507 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 6.0 t0 -111.25 141.86 44.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.459 -0.791 . . . . 1.41 110.336 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 702' ' ' LEU . 2.7 p -113.98 100.13 8.18 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.453 0.644 . . . . 0.8 109.741 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.642 HG21 ' NZ ' ' A' ' 627' ' ' LYS . 5.9 t -76.82 70.41 3.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.311 -0.859 . . . . 1.56 110.501 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.595 ' O ' HD23 ' A' ' 644' ' ' LEU . . . 63.58 30.4 77.5 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.399 -0.905 . . . . 0.98 111.622 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.696 HD12 ' CA ' ' A' ' 705' ' ' GLU . 0.3 OUTLIER -61.31 131.86 51.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.387 0.137 . . . . 1.49 110.705 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.627 ' HA ' HD13 ' A' ' 644' ' ' LEU . 1.4 p90 -46.63 -29.73 1.98 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.613 0.72 . . . . 1.85 109.823 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.752 ' ND2' ' H ' ' A' ' 706' ' ' GLY . 0.4 OUTLIER -155.43 -52.09 0.09 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.59 -1.186 . . . . 1.56 108.121 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.696 ' CA ' HD12 ' A' ' 702' ' ' LEU . 1.3 pt-20 146.92 -36.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 113.986 -1.461 . . . . 2.33 107.945 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.752 ' H ' ' ND2' ' A' ' 704' ' ' ASN . . . 140.42 80.84 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.486 -1.234 . . . . 1.69 111.853 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.499 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 0.5 OUTLIER -106.95 -10.21 16.04 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 122.404 -0.468 . . . . 2.43 111.675 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 113.89 8.63 17.67 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.697 -0.764 . . . . 2.99 112.931 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 7.6 ptp 46.36 40.92 8.51 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.227 0.454 . . . . 3.22 112.227 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 712' ' ' GLU . 0.3 OUTLIER 45.69 -154.68 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.556 -0.293 . . . . 6.1 111.709 179.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . 0.525 ' H ' HD12 ' A' ' 710' ' ' LEU . 2.4 mm-40 14.08 -76.6 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.064 0.946 . . . . 8.51 112.37 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' A' ' 710' ' ' LEU . 2.0 mm-40 -65.23 96.84 0.23 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.424 -0.584 . . . . 5.49 109.424 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -93.66 100.67 12.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.632 -0.713 . . . . 4.53 111.761 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.492 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.1 OUTLIER 47.15 87.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.707 -0.679 . . . . 1.42 112.469 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.4 141.24 45.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.965 -0.561 . . . . 0.66 109.93 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.726 HG23 ' CG ' ' A' ' 662' ' ' ASN . 95.7 t -90.99 130.17 40.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.932 0.396 . . . . 1.24 111.337 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.448 HD12 ' N ' ' A' ' 717' ' ' LEU . 5.2 mp -108.57 168.43 9.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.954 -0.566 . . . . 0.97 110.725 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.06 150.44 20.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 2.52 110.925 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -89.87 154.37 19.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.75 110.945 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.2 p -126.07 -174.06 3.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.72 111.313 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.51 -31.94 62.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.54 111.213 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -57.73 -51.94 67.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 2.11 110.823 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.716 ' HA ' HD12 ' A' ' 726' ' ' LEU . 0.4 OUTLIER -67.16 -48.48 67.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 1.91 110.781 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.465 ' O ' HG12 ' A' ' 727' ' ' VAL . 27.4 ttmt -60.5 -32.76 71.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.473 . . . . 2.55 111.028 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -63.87 -39.14 93.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 1.83 111.172 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.716 HD12 ' HA ' ' A' ' 723' ' ' GLU . 3.3 mt -62.18 -44.3 96.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.395 -0.366 . . . . 0.47 110.962 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 724' ' ' LYS . 10.4 p -72.84 -28.48 27.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.341 -0.39 . . . . 0.74 110.98 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -56.33 -34.67 66.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 2.43 110.9 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -98.3 28.84 3.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 2.71 110.828 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.476 HD12 ' CG ' ' A' ' 602' ' ' PHE . 5.6 tt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.198 -0.906 . . . . 1.5 110.744 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 599' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.839 0.352 . . . . 6.32 111.171 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' P' P ' 600' ' ' VAL . . . . . 0.401 HG22 ' N ' ' P' ' 601' ' ' GLU . 10.9 p -126.09 153.71 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 3.92 111.133 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 601' ' ' GLU . . . . . 0.468 ' C ' HD12 ' P' ' 602' ' ' LEU . 8.7 mt-10 -166.59 44.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 3.86 110.872 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 602' ' ' LEU . . . . . 0.468 HD12 ' C ' ' P' ' 601' ' ' GLU . 5.3 mp -139.24 156.46 47.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 2.55 110.936 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 603' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' P' P ' 604' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -75.99 76.11 2.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 2.02 110.813 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 605' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -63.99 115.55 5.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 2.42 110.928 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 606' ' ' LEU . . . . . 0.674 HD13 ' CG ' ' A' ' 683' ' ' ASP . 13.0 mt -79.24 153.32 76.85 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 1.38 110.875 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 607' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 C--O 1.25 1.091 0 C-N-CA 122.536 2.157 . . . . 2.72 112.294 -179.958 . . . . . . . . 0 0 . 1 stop_ save_